Delivery Order SPE2DB25D3504-SPE2DB25FVUCJ

Award Date 4/4/25
Potential Completion Date 4/7/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,379.49, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,249.70, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025 and is a firm-fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.50, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order contract with a completion date of January 30, 2025. This award is not associated with a set-aside designation. In addition to this specific delivery order,...
This contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,358.22 firm fixed price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $2,699.47. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,378.28, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,706.61, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is March 25, 2025. The award was made on March 24, 2025, and there is no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,084.04, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. It is a firm fixed-price contract with a period of performance through March 31, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,855.98 firm-fixed-price contract is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has a performance period through June 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,022.43, is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024 and is a firm fixed price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVUCJ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,893.62, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. The contract is a firm fixed-price delivery order that runs through April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/4/25, 11:13 AM